login
login
Image header Agence Europe
Europe Daily Bulletin No. 9507
Contents Publication in full By article 15 / 39
GENERAL NEWS / (eu) eu/medicines

21/09/2007 (Agence Europe) - The European Medicines Agency (EMEA) has decided to recommend that the suspension of the marketing authorisation for Viracept (nelfinavir) from the Swiss laboratory, Roche, should be lifted. Marketing authorisation for Viracept had been suspended and the product withdrawn from the market following the discovery that the product was contaminated by a known genotoxic substance, ethyl mesilate. (oj)

Contents

A LOOK BEHIND THE NEWS
THE DAY IN POLITICS
GENERAL NEWS
TIMETABLE